Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy—final results of the larynx organ preservation trial DeLOS-II

Andreas Dietz(Klinik und Poliklinik für Hals-, Nasen-, Ohrenheilkunde), Ulrich Keilholz(German Cancer Research Center), Markus Jungehülsing, Rudolf Hagen(University of Würzburg), Thomas Foerg(St. Vincentius-Kliniken), Oliver Kölbl(University Hospital Regensburg), Barbara Wollenberg(Klinik und Poliklinik für Hals-, Nasen-, Ohrenheilkunde), Maike de Wit(Florida Hospital Cancer Institute), Holger Sudhoff(Bielefeld University), J. Bünzel(Südharz Klinikum), Petra Feyer(Vivantes Klinikum), Volker Budach(Humboldt-Universität zu Berlin), J. Strutz(University of Regensburg), Michael Flentje(Universitätsklinikum Würzburg), Florian Lordick(Leipzig University), L. Pfreundner(University of Würzburg), Frank Schreiber(Otto-von-Guericke-Universität Magdeburg), Jens Peter Klußmann(Lungenklinik Köln-Merheim), Swantje Held(AIO Studien gGmbH), Ulrike Bockmühl(Klinikum Kassel), Matthias Scheich(University of Würzburg), Andreas Boehm(Klinikum St. Georg), H.-J. Welkoborsky(KRH Klinikum Nordstadt), Thomas Kuhnt(Leipzig University), Georg Maschmeyer(Radboud University Medical Center), Maren Knödler(Humboldt-Universität zu Berlin), Orlando Guntinas‐Lichius(Jena University Hospital), S. Remmert(Malteser Krankenhaus St. Anna), Matthias Hautmann, Christian Sittel(Katharinenhospital), Thomas Lenarz(Hannover Re (Germany)), Susanne Wiegand, Ursula C. Schroeder(University of Lübeck), Gunnar Wichmann(Leipzig University of Applied Sciences), Martin Görner(Klinikum Bielefeld), Klaus Vogel, Martin Westhofen, Marc Münter(Stuttgart Observatory), Serena Preyer(St. Vincentius-Kliniken), Claudia Rudack(Klinik und Poliklinik für Hals-, Nasen-, Ohrenheilkunde), Hans Theodor Eich(University Hospital Münster), Dietmar Thurnher(Vienna General Hospital)
Annals of Oncology
August 22, 2018
10.1093/annonc/mdy332
Cited by 83

Related Papers

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
|The Lancet|2010|7.3k
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Gastric cancer
|The Lancet|2020|4.8k
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
|The Lancet Infectious Diseases|2019|1.7k
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
|The Lancet|2018|1.7k